Stryker, a global leader in medical technologies, has announced the successful completion of the first European surgeries utilizing the Infinity Total Ankle System featuring Adaptis and Everlast technology.

These initial procedures were performed by Mr. David N. Townshend FRCS (Orth), Consultant Trauma & Orthopaedic Surgeon at North Tyneside General Hospital, United Kingdom, marking the commencement of the UK Infinity with Adaptis and Everlast study.

"We are thrilled to have implanted the first patient using Stryker’s Infinity Total Ankle System with Adaptis and Everlast technology as part of the UK post-market clinical study," said Mr. Townshend.

"This new technology marks the next step of the Infinity Total Ankle System which has already shown promising outcomes and survivorship for our patients with end-stage ankle arthritis. We look forward to sharing the results of this clinical study."

Vice President and General Manager of Stryker’s European Trauma & Extremities business, commented, "Infinity with Adaptis builds on the legacy of the original Infinity Total Ankle, with a decade of clinical use. Recent publication data showed a 98.8% survivorship at two years of the original Infinity implant, demonstrating its safety and efficacy as a low-profile prosthesis for surgeons treating end-stage ankle arthritis.

These initial procedures highlight Stryker's dedication to innovation and commitment through research, enhancing our collaboration with surgeons."

The Infinity Total Ankle System comprises a titanium alloy tibial tray, cobalt chromium talar dome, and polyethylene insert. The Adaptis 3D-printed total ankle implants incorporate porous metal components designed to facilitate boney ingrowth.

The Everlast highly cross-linked polyethylene inserts, blended with vitamin E, have been shown to improve wear resistance. The interchangeability of the two talar options adds versatility to the system, designed to cater to diverse patient needs.

Furthermore, the system is optimized for efficiency through Prophecy Surgical Planning, which includes patient-specific instruments.

 

 

Source: businesswire.com

Report Abuse